Home > Qtrly Results > AUROBINDO PHARMA

AUROBINDO PHARMA
Quarterly Results Analysis [Dec2023]

AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹7,352 Cr ₹7,219 Cr ₹6,851 Cr ₹6,473 Cr ₹6,407 Cr ₹5,739 Cr ₹6,236 Cr ₹5,809 Cr
Expenses ₹5,750 Cr ₹5,846 Cr ₹5,699 Cr ₹5,471 Cr ₹5,453 Cr ₹4,949 Cr ₹5,299 Cr ₹4,835 Cr
Operating Income ₹1,601 Cr ₹1,373 Cr ₹1,151 Cr ₹1,002 Cr ₹954 Cr ₹791 Cr ₹936 Cr ₹974 Cr
Other Income ₹163 Cr ₹187 Cr ₹116 Cr ₹135 Cr ₹93 Cr ₹57 Cr ₹41 Cr ₹49 Cr
Interest ₹76 Cr ₹68 Cr ₹57 Cr ₹56 Cr ₹45 Cr ₹25 Cr ₹15 Cr ₹9 Cr
Depreciation ₹423 Cr ₹418 Cr ₹327 Cr ₹346 Cr ₹321 Cr ₹298 Cr ₹280 Cr ₹254 Cr
Profit Before Tax ₹1,265 Cr ₹1,075 Cr ₹815 Cr ₹736 Cr ₹681 Cr ₹525 Cr ₹683 Cr ₹598 Cr
Profit After Tax ₹943 Cr ₹751 Cr ₹573 Cr ₹512 Cr ₹492 Cr ₹412 Cr ₹524 Cr ₹580 Cr
EPS ₹15.98 ₹12.92 ₹9.74 ₹8.64 ₹8.38 ₹6.99 ₹8.88 ₹9.84
Industry Peers & Returns1W1M1Y
AUROBINDO PHARMA 6.4% 0.8% 117.4%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

AUROBINDO PHARMA Quarterly Revenues

Revenues
Q-o-Q

1.83 %

Y-o-Y

14.74 %

Quarters Revenues % Change
Dec2023 ₹7,352 Cr
1.83
Sep2023 ₹7,219 Cr
5.38
Jun2023 ₹6,851 Cr
5.83
Mar2023 ₹6,473 Cr
1.03
Dec2022 ₹6,407 Cr
11.63
Sep2022 ₹5,739 Cr
-7.96
Jun2022 ₹6,236 Cr
7.34
Mar2022 ₹5,809 Cr -

AUROBINDO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

16.59 %

Y-o-Y

67.78 %

Quarters Operating Profit % Change
Dec2023 ₹1,601 Cr
16.59
Sep2023 ₹1,373 Cr
19.29
Jun2023 ₹1,151 Cr
14.89
Mar2023 ₹1,002 Cr
5.01
Dec2022 ₹954 Cr
20.69
Sep2022 ₹791 Cr
-15.56
Jun2022 ₹936 Cr
-3.89
Mar2022 ₹974 Cr -
Operating Margins
Q-o-Q

14.51 %

Y-o-Y

46.17 %

Quarters Operating Margin% % Change
Dec2023 21.78%
14.51
Sep2023 19.02%
13.15
Jun2023 16.81%
8.59
Mar2023 15.48%
3.89
Dec2022 14.9%
8.13
Sep2022 13.78%
-8.26
Jun2022 15.02%
-10.44
Mar2022 16.77% -

AUROBINDO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

25.50 %

Y-o-Y

91.73 %

Quarters Profit After Tax % Change
Dec2023 ₹943 Cr
25.50
Sep2023 ₹751 Cr
31.18
Jun2023 ₹573 Cr
11.87
Mar2023 ₹512 Cr
4.10
Dec2022 ₹492 Cr
19.44
Sep2022 ₹412 Cr
-21.50
Jun2022 ₹524 Cr
-9.63
Mar2022 ₹580 Cr -
PAT Margins
Q-o-Q

23.27 %

Y-o-Y

67.14 %

Quarters PAT Margin(%) % Change
Dec2023 12.82 %
23.27
Sep2023 10.4 %
24.40
Jun2023 8.36 %
5.69
Mar2023 7.91 %
3.13
Dec2022 7.67 %
6.97
Sep2022 7.17 %
-14.74
Jun2022 8.41 %
-15.82
Mar2022 9.99 % -

AUROBINDO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

23.68 %

Y-o-Y

90.69 %

Quarters EPS % Change
Dec2023 ₹15.98
23.68
Sep2023 ₹12.92
32.65
Jun2023 ₹9.74
12.73
Mar2023 ₹8.64
3.10
Dec2022 ₹8.38
19.89
Sep2022 ₹6.99
-21.28
Jun2022 ₹8.88
-9.76
Mar2022 ₹9.84 -

You may also like the below Video Courses